{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hemolytic-anemia-due-to-erythrocyte-adenosine-deaminase-overproduction","columns":[{"gene":"","key":"population-c2b5a74a4150781f24fb","label":"Hemolytic anemia due to elevated adenosine deaminase","mondoId":"MONDO:0020458","onsetQualifier":null,"originColumnKey":"MONDO:0020458/OMIM:301083","originalViews":[{"key":"MONDO:0020458/OMIM:301083","label":"Hemolytic anemia due to elevated adenosine deaminase","scopeLabel":"OMIM:301083","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["18b431f016b3c8ff3339a14606847273d22f66fe5fa9096f355ea6133be64f24","291d71e00013ca08f9d53cd7446f44b36bc59a0123758ffe70c4ec0334d5bf4a","5ea60dc693a5f44cb8dad12886efd5763fe9f8699e23edd39c1bab9b90ee7a5a","67482a5e654e0274e06c9de5d25166d4597de69166af3d6e03557049b5334206","80b59fe58c3e87d3b3bcea523c3dd9ef2d08520b7100f67e67df39f7671f102d","942e97dd8bf12fd498247733869c4a999fcff34bcba4514d4223472de81ccb00"],"recordQualifiers":{},"scopeLabel":"OMIM:301083","sourceIds":["OMIM:301083"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c2b5a74a4150781f24fb"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012132","HP:0001878","HP:0002904","HP:4000184","HP:0001923","HP:0004446"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":6,"sourceGroups":{"published":6}},"features":[{"hpoId":"HP:0012132","label":"Erythroid hyperplasia","primary":true},{"hpoId":"HP:0001878","label":"Hemolytic anemia","primary":true},{"hpoId":"HP:0002904","label":"Hyperbilirubinemia","primary":true},{"hpoId":"HP:4000184","label":"Reduced erythrocyte adenosine triphosphate concentration","primary":true},{"hpoId":"HP:0001923","label":"Reticulocytosis","primary":true},{"hpoId":"HP:0004446","label":"Stomatocytosis","primary":true}],"ledeHtml":"Hemolytic anemia due to erythrocyte adenosine deaminase overproduction is a rare, genetic, hematologic disease characterized by mild, chronic hemolytic anemia (due to highly elevated adenosine deaminase activity in red blood cells resulting in their premature destruction), elevated reticulocyte count, splenomegaly and mild hyperbilirubinemia. Other cells and tissues are not affected.","mondoId":"MONDO:0020458","node":{"canonicalSlug":"hemolytic-anemia-due-to-erythrocyte-adenosine-deaminase-overproduction","comparisons":[{"documentSha256":"6be5932f09efa151ab49974ed8962bd3c712abe14821f84d441f6a3b86e862d1","key":"legacy-hemolytic-anemia-due-to-erythrocyte-adenosine-deaminase-overproduction","kind":"legacy","label":"hemolytic anemia due to erythrocyte adenosine deaminase overproduction","memberIds":["MONDO:0020458"],"mondoId":"MONDO:0020458","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hemolytic-anemia-due-to-erythrocyte-adenosine-deaminase-overproduction.6be5932f09efa151ab49974ed8962bd3c712abe14821f84d441f6a3b86e862d1.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hemolytic anemia due to erythrocyte adenosine deaminase overproduction","originalSourceId":"ORPHA:99138","paragraphs":["Hemolytic anemia due to erythrocyte adenosine deaminase overproduction is a rare, genetic, hematologic disease characterized by mild, chronic hemolytic anemia (due to highly elevated adenosine deaminase activity in red blood cells resulting in their premature destruction), elevated reticulocyte count, splenomegaly and mild hyperbilirubinemia. Other cells and tissues are not affected."],"rawAttribution":"MONDO:0020458","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:30Z","upstream":"MONDO:0020458","url":"https://rarediseases.info.nih.gov/diseases/19669"},"ownColumnKeys":["population-c2b5a74a4150781f24fb"],"publication":"published","relationships":[{"kind":"parent","label":"congenital nonspherocytic hemolytic anemia","mondoId":"MONDO:0006506","slug":"congenital-nonspherocytic-hemolytic-anemia"},{"kind":"parent","label":"inborn disorder of purine metabolism","mondoId":"MONDO:0019236","slug":"inborn-disorder-of-purine-metabolism"},{"kind":"parent","label":"anemia due to enzyme disorder","mondoId":"MONDO:0020584","slug":"anemia-due-to-enzyme-disorder"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"18b431f016b3c8ff3339a14606847273d22f66fe5fa9096f355ea6133be64f24","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:301083","disease_name":"Hemolytic anemia due to elevated adenosine deaminase","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012132","is_excluded":false,"label":"Erythroid hyperplasia","onset_id":null,"reference":"PMID:3164080","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"291d71e00013ca08f9d53cd7446f44b36bc59a0123758ffe70c4ec0334d5bf4a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:301083","disease_name":"Hemolytic anemia due to elevated adenosine deaminase","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0004446","is_excluded":false,"label":"Stomatocytosis","onset_id":null,"reference":"PMID:3164080","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5ea60dc693a5f44cb8dad12886efd5763fe9f8699e23edd39c1bab9b90ee7a5a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:301083","disease_name":"Hemolytic anemia due to elevated adenosine deaminase","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001923","is_excluded":false,"label":"Reticulocytosis","onset_id":null,"reference":"PMID:3164080","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"67482a5e654e0274e06c9de5d25166d4597de69166af3d6e03557049b5334206","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:301083","disease_name":"Hemolytic anemia due to elevated adenosine deaminase","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001878","is_excluded":false,"label":"Hemolytic anemia","onset_id":null,"reference":"PMID:3164080","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"80b59fe58c3e87d3b3bcea523c3dd9ef2d08520b7100f67e67df39f7671f102d","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:301083","disease_name":"Hemolytic anemia due to elevated adenosine deaminase","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:4000184","is_excluded":false,"label":"Reduced erythrocyte adenosine triphosphate concentration","onset_id":null,"reference":"PMID:3164080","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"942e97dd8bf12fd498247733869c4a999fcff34bcba4514d4223472de81ccb00","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:301083","disease_name":"Hemolytic anemia due to elevated adenosine deaminase","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002904","is_excluded":false,"label":"Hyperbilirubinemia","onset_id":null,"reference":"PMID:3164080","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/19669\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0020458\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0020458</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hemolytic anemia due to erythrocyte adenosine deaminase overproduction is a rare, genetic, hematologic disease characterized by mild, chronic hemolytic anemia (due to highly elevated adenosine deaminase activity in red blood cells resulting in their premature destruction), elevated reticulocyte count, splenomegaly and mild hyperbilirubinemia. Other cells and tissues are not affected.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/19669\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hemolytic-anemia-due-to-erythrocyte-adenosine-deaminase-overproduction","sourceDocuments":[{"name":"GARD: Hemolytic anemia due to erythrocyte adenosine deaminase overproduction","reviewed":null,"source_release":"2026-10-21T17:03:30Z","url":"https://rarediseases.info.nih.gov/diseases/19669"},{"name":"MONDO: hemolytic anemia due to erythrocyte adenosine deaminase overproduction","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0020458"}],"sourceNote":"","synonyms":["adenosine deaminase, elevated, hemolytic anaemia due to","adenosine deaminase, elevated, hemolytic anemia due to","anemia, congenital, nonspherocytic hemolytic, 9"],"takeawayHtml":"","title":"hemolytic anemia due to erythrocyte adenosine deaminase overproduction"},"schemaVersion":1}
